Drug intelligence / Profile preview

Ibuprofen + caffeine

Development stage
Phase 3
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + caffeine is a fixed-dose combination of two active ingredients used primarily for the treatment of acute pain, such as postoperative pain and tension-type headaches. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Caffeine, a methylxanthine stimulant, enhances the analgesic effect of ibuprofen by antagonizing adenosine receptors in the brain and may also aid in faster absorption of ibuprofen. Clinical studies have shown that this combination provides superior pain relief compared to either agent alone, with faster onset and greater efficacy for moderate to severe acute pain[1][2][3][4][5].

Brand names
Thomapyrin Tension DuoSpalt ForteAdvil Caffeine
Other names
Ibuprofen/Caffeine FDCIbuprofen/Caffeine 400mg/100mgFixed-dose combination of ibuprofen and caffeine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)ADORA2A (Adenosine A₂A Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on Ibuprofen + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ibuprofen + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call